Strains |
|
|
S. avermitilis
|
|
|
ATCC 31267 |
WT strain |
Laboratory stock |
A-178 |
An industrial strain |
Qilu Pharmaceutical |
ΔaveT |
aveT deletion mutant |
This study |
CaveT |
aveT-complemented strain |
This study |
OaveT |
aveT-overexpressing strain |
This study |
OaveT/A-178 |
aveT-overexpressing strain based on A-178 |
This study |
WT/pKC1139 |
WT strain carrying empty vector pKC1139 |
This study |
WT/pSET152 |
WT strain carrying empty vector pSET152 |
This study |
ΔaveM |
aveM deletion mutant |
This study |
CaveM |
aveM-complemented strain |
This study |
OaveM |
aveM-overexpressing strain |
This study |
ΔaveM/A-178 |
aveM deletion mutant based on A-178 |
This study |
ΔaveTaveM |
aveT aveM double deletion mutant |
This study |
OpepD2 |
pepD2-overexpressing strain |
This study |
Δaco |
aco deletion mutant |
This study |
E. coli
|
|
|
JM109 |
General cloning host for plasmid manipulation |
Laboratory stock |
ET12567 |
Methylation-deficient strain |
33 |
BL21(DE3) |
Host for protein overexpression |
Novagen |
Plasmids |
|
|
pKC1139 |
Multiple-copy, temperature-sensitive E. coli-Streptomyces shuttle vector |
48 |
pSET152 |
Integrative E. coli-Streptomyces shuttle vector |
48 |
pET-28a (+) |
Vector for protein overexpression in E. coli
|
Novagen |
pJL117 |
pIJ2925 derivative carrying the Streptomyces strong constitutive promoter ermE*p
|
49 |
pΔaveT |
aveT deletion vector based on pKC1139 |
This study |
pKC1139-ermp-aveT |
aveT-overexpressing vector based on pKC1139 |
This study |
pSET152-aveT |
aveT-complemented vector based on pSET152 |
This study |
pET28-aveT |
aveT-overexpressing vector based on pET-28a (+) |
This study |
pΔaveM |
aveM deletion vector based on pKC1139 |
This study |
pKC1139-ermp-aveM |
aveM-overexpressing vector based on pKC1139 |
This study |
pSET152-aveM |
aveM-complemented vector based on pSET152 |
This study |
pKC1139-ermp-pepD2 |
pepD2-overexpressing vector based on pKC1139 |
This study |
pΔaco |
aco deletion vector based on pKC1139 |
This study |